Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.405 USD | +6.58% | +1.25% | -97.79% |
06-10 | Panbela Therapeutics, Inc. Announces Oral Presentation at Digestive Disease Week | CI |
05-17 | North American Morning Briefing : The "Everything -2- | DJ |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.97M 155M |
---|---|---|---|---|---|
Net income 2024 * | -27M -2.13B | Net income 2025 * | -34M -2.69B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.05
x | P/E ratio 2025 * |
-0.09
x | Employees | 8 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 100% |
Latest transcript on Panbela Therapeutics, Inc.
1 day | +6.58% | ||
1 week | +1.25% | ||
Current month | +1.25% | ||
1 month | +1.22% | ||
3 months | -39.43% | ||
6 months | -98.31% | ||
Current year | -97.79% |
Date | Price | Change | Volume |
---|---|---|---|
20/06/24 | 0.405 | +6.58% | 27,032 |
18/06/24 | 0.38 | -10.80% | 18,122 |
17/06/24 | 0.426 | +3.90% | 5,251 |
14/06/24 | 0.41 | +2.50% | 38,972 |
13/06/24 | 0.4 | 0.00% | 9,603 |
Delayed Quote OTC Markets, June 20, 2024 at 08:51 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-97.79% | 1.97M | |
+35.14% | 51.51B | |
-7.43% | 39.03B | |
+35.88% | 38.91B | |
-10.62% | 26.68B | |
+11.63% | 26.13B | |
-17.77% | 19.91B | |
+40.52% | 13.71B | |
+30.70% | 12.38B | |
-3.41% | 11.74B |
- Stock Market
- Equities
- SNBP Stock